To view this email as a web page, click here.
April 4, 2017
 
ADVERTISEMENT
Ad description here
 
PHARMACISTS' REPORT
 
Pot and Health Economics: The Pharmacist's Role
Even medical marijuana has health-care costs and outcomes.
Read more
 
ADVERTISEMENT
 
What's in the Specialty Pharmacy Pipeline?
Here's a look at biosimilars, cancer agents, and orphan drugs heading toward FDA approval in 2017.
Read more
 
WHO Launches Program to Reduce Medication Errors
How a program hopes to cut errors in half.
Read more
 
Finding Time to Counsel Patients: Make It the Priority
Do you make patient education the most important part of your day?
Read more
 
ADVERTISEMENT
Should you choose an independent distributor?
As an independent pharmacist, you may be subsidizing big box competitors when you work with a large distributor. What steps can you take to stop funding the competition? Read this Drug Topics Partner Perspective to learn more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.